​

Adlai Nortye Ownership | Who Owns Adlai Nortye?

OverviewChart

Adlai Nortye Ownership Summary

Adlai Nortye is owned by 108.71% institutional investors, 5.66% insiders. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 0% of ANL shares. Tema Oncology ETF is the top mutual fund, with 0.08% of its assets in Adlai Nortye shares.

ANL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAdlai Nortye108.71%5.66%-14.37%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Price t rowe associates inc /md/---
Eversource wealth advisors---
Cantor fitzgerald, l. p.---
Dymon asia capital (singapore) pte.---
Td asset management---
Persistent asset partners---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Price t rowe associates inc /md/---
Eversource wealth advisors---
Cantor fitzgerald, l. p.---
Dymon asia capital (singapore) pte.---
Td asset management---
Persistent asset partners---

Top Buyers

HolderShares% AssetsChange
Eversource wealth advisors---4.79K
Dymon asia capital (singapore) pte.---15.00K
Persistent asset partners---33.73K
Td asset management---35.75K
Cantor fitzgerald, l. p.---40.31K

Top Sellers

HolderShares% AssetsChange
Price t rowe associates inc /md/---99.84K
Cantor fitzgerald, l. p.---40.31K
Td asset management---35.75K
Persistent asset partners---33.73K
Dymon asia capital (singapore) pte.---15.00K

Sold Out

HolderChange
Eversource wealth advisors-4.79K
Dymon asia capital (singapore) pte.-15.00K
Persistent asset partners-33.73K
Td asset management-35.75K
Cantor fitzgerald, l. p.-40.31K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202626550.00%11,586,54720659.96%10839640.94%25733.33%--100.00%
Dec 31, 20254-55,812243.18%-2248.89%3200.00%1-66.67%
Sep 30, 20254-16,263-72.75%-48.52%1-75.00%3-
Jun 30, 20254-59,6825.52%-198.53%4100.00%--100.00%
Mar 31, 2025433.33%56,560-0.58%-185.97%2-1-66.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Tema Oncology ETF45.40K0.08%-
Virtus LifeSci Biotech Clinical Trls ETF30.12K0.05%-
Fidelity Nasdaq Composite Index11.13K0.02%-
Telescope Biotech Fund A FIL8.95K0.02%-
JHVIT Health Sciences I1.71K0.00%1.71K
EQ/T. Rowe Price Health Sciences IB1.21K0.00%1.21K

Recent Insider Transactions

DateNameRoleActivityValue
May 13, 2026LU YANG CEOSell$131.80
Apr 26, 2006BLATZ ROBERT G President and COOSell$20.21K
Apr 24, 2006BLATZ ROBERT G President and COOSell$13.47K
Apr 21, 2006BLATZ ROBERT G President and COOSell$13.51K
Apr 20, 2006BLATZ ROBERT G President and COOSell$13.47K

Insider Transactions Trends

DateBuySell
2029 Q1--
2026 Q2-1
2026 Q1--
2024 Q3--
2022 Q3--

ANL Ownership FAQ

Who Owns Adlai Nortye?

Adlai Nortye shareholders are primarily institutional investors at 108.71%, followed by 5.66% insiders and -14.37% retail investors. The average institutional ownership in Adlai Nortye's industry, Biotech Stocks , is 35.43%, which Adlai Nortye exceeds.

Who owns the most shares of Adlai Nortye?

Adlai Nortye’s largest shareholders are Price t rowe associates inc /md/ (0 shares, 0%), Eversource wealth advisors (0 shares, 0%), and Cantor fitzgerald, l. p. (0 shares, 0%). Together, they hold 0% of Adlai Nortye’s total shares outstanding.

Does Blackrock own Adlai Nortye?

BlackRock is not among the top 10 institutional shareholders of Adlai Nortye.

Who is Adlai Nortye’s biggest shareholder by percentage of total assets invested?

Price t rowe associates inc /md/ is Adlai Nortye’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Adlai Nortye shares, valued at 0$.

Who is the top mutual fund holder of Adlai Nortye shares?

Tema Oncology ETF is the top mutual fund holder of Adlai Nortye shares, with 0.08% of its total shares outstanding invested in 45.4K Adlai Nortye shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools